|
2011
|
Invention
|
Calcitonin products and therapies for treating inflammatory or degenerative diseases. Calcitonin ... |
|
2010
|
Invention
|
Peptide pharmaceuticals for nasal delivery. Pharmaceutical products for nasal administration cont... |
|
|
Invention
|
Treatment for obesity. The present invention provides peptides and pharmaceutical compositions th... |
|
2008
|
Invention
|
Peptide pharmaceutical for oral delivery. Acid-containing oral pharmaceutical compositions are pr... |
|
|
Invention
|
Method for fostering bone formation and preservation.
A method of inducing bone formation in a s... |
|
|
Invention
|
Method for fostering bone formation and preservation. A method of inducing bone formation in a su... |
|
2007
|
Invention
|
Methods and compositions for fostering and preserving bone growth. A method for augmenting bone i... |
|
|
Invention
|
Glyoxylate assays and their use for identifying natural amidated compounds. Methods for detecting... |
|
|
Invention
|
Glyoxylate assays and their use of inden tifying natural amidated compounds.
Methods for detecti... |
|
2006
|
Invention
|
Fast-acting oral peptide pharmaceutical products. A finished pharmaceutical product adapted for o... |
|
|
Invention
|
Cell lines for expressing enzyme useful in the preparation of amidated products. Cell lines are p... |
|
|
Invention
|
Amidated parathyroid hormone fragments and uses thereof.
C-terminal amidated human parathyroid h... |
|
|
Invention
|
Bone implant device and methods of using same. A bone implant device comprising a plurality of in... |
|
|
Invention
|
Bone implant device and methods of using same.
A bone implant device comprising a plurality of i... |
|
2005
|
Invention
|
Enzymatic reactions in the presence of keto acids. Conversion in vitro of X-Gly to X-alpha-hydrox... |
|
|
Invention
|
Improving bone formation and preservation by surgically inducing an increase in osteoblast activi... |
|
|
Invention
|
Oral delivery of peptide pharmaceutical compositions. Bioavailability of peptide active agents to... |
|
|
Invention
|
Improved bacterial host cell for the direct expression of peptides. Expression systems 035 4i2A1>... |
|
|
Invention
|
Amidated parathyroid hormone fragments and uses thereof. C-terminal amidated human parathyroid ho... |
|
2004
|
Invention
|
Improved oral delivery of peptides. Bioavailability of peptide active agents to be administered o... |
|
2002
|
Invention
|
Oral peptide pharmaceutical dosage form and method of production. A pharmaceutical composition fo... |
|
2001
|
Invention
|
Improved oral delivery of peptides using enzyme-cleavable membrane translocators. Bioavailability... |
|
|
Invention
|
Nasal calcitonin formulations. A liquid pharmaceutical composition is disclosed comprising calcit... |
|
1998
|
Invention
|
Direct expression of peptides into culture media. Expression systems are disclosed for the direct... |
|
1997
|
Invention
|
Oral peptide pharmaceutical products. Bioavailability of peptide active agents to be administered... |
|
1987
|
Invention
|
Alpha-amidating enzyme compositions and processes for their production and use. Purified enzymati... |
|
1985
|
Invention
|
Alpha-amidation enzyme. Peptidyl-glycine α-amidating monooxygenase is an enzyme extractable from ... |
|
|
Invention
|
Immunization by immunogenic implant. Induction of immune response is achieved by implantation of ... |
